Combined therapy for weight loss and muscle weakness in kidney dialysis
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study tests a program combining exercise, nutritional support, and omega-3 supplements to help kidney dialysis patients who have lost weight and muscle strength. It aims to improve appetite, energy levels, and physical function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be on hemodialysis (a treatment that filters your blood) for more than 3 months.
- You have lost at least 5% of your body weight without swelling in the last 12 months, or your body mass index (BMI) is below 20.
- You feel that your physical function, muscle strength, or appetite has decreased, and you feel more tired than usual.
- You are over 18 years old.
- You have not taken fish oil or omega-3 supplements in the past 3 months and are not currently in any exercise or fish oil study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria might affect weight loss in people with kidney failure who are on dialysis. It may help find new ways to prevent or treat weight loss in this condition.
This study tests if a special drink can improve nutrition and quality of life in people with chronic kidney disease (CKD) who are not on dialysis. It is for those who have lost weight or have poor appetite.
This trial tests whether receiving extra nutrition during your dialysis sessions can help maintain or build muscle over time. It is for people on long-term hemodialysis who have very low urine output and a well-functioning access point (fistula).
This trial tests if a protein supplement during dialysis sessions can help people on maintenance dialysis maintain or improve their nutrition. It looks for participants who have been on dialysis for at least three months and are not severely malnourished.
This study tests a program to help people with chronic kidney disease (CKD) stay healthy through diet tracking and other proactive steps. It focuses on people whose kidney function has declined but who are not yet on dialysis.
This trial tests whether a drug called roxadustat can help treat muscle loss (sarcopenia) in people on hemodialysis. It aims to see if improving anemia also strengthens muscles.
Hear when a new Cachexia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.